BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Biotech Bay

  Alkahest Receives Grant From Michael J. Fox Foundation; Funding Will Support the Clinical Development of a Novel Parkinson’s Therapy

  GRF6019 is a plasma-derived product in clinical development for the treatment of neurodegenerative diseases.

  February 12, 2018

   · 

  3 min read
• Business

  Medicenna Reports Third Quarter Fiscal 2018 Financial Results

  Medicenna today reported financial results for the three and nine months ended December 31, 2017.

  February 12, 2018

   · 

  10 min read
• 

  Business

  Cambridge’s Surface Oncology Promotes CBO to Top Job

  Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors.

  February 12, 2018

   · 

  3 min read
• Drug Development

  Concert Pharmaceuticals Announces Initiation of Enrollment in Second Cohort of CTP-543 Phase IIa Trial for Alopecia Areata

  Concert Pharmaceuticals today announced that it has initiated enrollment of the second cohort of its Phase 2a clinical trial evaluating CTP-543.

  February 12, 2018

   · 

  6 min read
• Drug Development

  Ra Pharmaceuticals Announces Completion of Dosing in Phase II Program of RA101495 SC in Paroxysmal Nocturnal Hemoglobinuria

  Ra Pharmaceuticals announced today the completion of dosing and topline data for the Company’s global Phase 2 clinical program evaluating RA101495 SC for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).

  February 12, 2018

   · 

  8 min read
• Pharm Country

  PAVmed to Offer Opportunity to Exchange Outstanding Warrants

  PAVmed today announced it intends to file exchange offer materials (the “Exchange”) providing the holders of the Company’s outstanding Series W Warrants (Nasdaq: PAVMW, the “W Warrant”) with the opportunity to exchange 2 W Warrants for 1 Series Z Warrant (the “Z Warrant”).

  February 12, 2018

   · 

  6 min read
• Business

  ImmunoMet Appoints Vincent J. O’Neill, M.D., B.Sc., M.R.C.P, as CMO, and Allan L. Shaw as CFO

  Dr. O’Neill, a medical oncologist, joins ImmunoMet with 16 years of oncology therapeutic and diagnostic product development experience at both large pharma and biotech companies.

  February 12, 2018

   · 

  3 min read
• Propanc Biopharma Provides Shareholder Update and Goals for 2018

  Since the beginning of 2017, the Company has initiated and completed a number of activities.

  February 12, 2018

   · 

  6 min read
• Business

  Metrion Biosciences Establishes Scientific Advisory Board

  The members of the SAB have been selected for their extensive and diverse experience in ion channel screening, cardiac safety testing, neuroscience research and native tissue and human stem cell translational assays, all of which are fields of interest to Metrion.

  February 12, 2018

   · 

  2 min read
• Pharm Country

  DSG Attending Outsourcing in Clinical Trials Conference in Burlingame, Calif.

  The conference will be held from February 21-22, 2018 at the Hyatt Regency San Francisco Airport.

  February 12, 2018

   · 

  2 min read